基因组扩增和转录组改变有助于突尼卡米辛耐药CHOK1细胞的生存和增强蛋白质分泌
1Department of Chemical Engineering, Indian Institute of Technology Bombay, Mumbai, India.
Biotechnology journal
|December 17, 2025
概括
适应性实验室进化 (ALE) 增强了用于生物治疗生产的中国仓鼠卵巢 (CHO) 细胞. 适应图尼卡米辛的CHO细胞显示蛋白质分泌和抗性增加,突出显示ALE是一种强大的细胞工程策略.
科学领域:
- 生物技术是生物技术.
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 中国仓鼠卵巢 (CHO) 细胞对于生物治疗生产至关重要.
- 提高CHO细胞的细胞生产率是一个持续的挑战.
- 适应性实验室进化 (ALE) 与奥米克分析相结合,为宿主细胞系工程提供了一种战略.
研究的目的:
- 为了提高使用ALE的CHO细胞的生产率.
- 研究适应细胞中蛋白质分泌量增加背后的分子机制.
主要方法:
- CHOK1细胞适应了尼胺素 (TM),这是一个内质网膜 (ER) 压力因子.
- 在适应细胞上进行了转录组分析和全基因组测序.
- 用SEAP的暂时表达来评估特定生产力.
主要成果:
- 适应TM细胞的TM抗性增加了8倍,并扩大了ER.
- 在适应细胞中,总蛋白质的每细胞分泌率增加了3到4倍.
- 观察到蛋白质处理,ER应激反应和信号通路基因的升级.
- 证实了包括Dpagt1在内的染色体4段的放大.
- 适应的单元显示SEAP特定生产率提高了约1.4倍.
结论:
- ALE是一种有效的策略,用于设计具有增强蛋白质生产的CHO细胞.
- 增加蛋白质分泌与转录性变化和基因组放大有关.
- 适应细胞在重组蛋白表达方面表现出提高的生产力.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
2.1K
09:01Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
811
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancer-Critical Genes I: Proto-oncogenes
11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
